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Cherubism is classified within the group of benign osteo-fibrous lesions. Aside from facial deformities, it may
account for major complications. It has been observed that the disease is caused by a mutation in the gene SH3BP2
(SH3-domain binding protein 2), which is located at chromosome 4pl6.3. Here we present two cases of familial
cherubism, uncle and nephew, with variable clinical involvement (“Expressivity”), and one case of a woman (sister
and mother, respectively), who transmitted cherubism without suffering the disease. In this article we have shown
that, in familial cherubism cases, the mutation is inherited through an autosomal dominant transmission. Mutations
affecting gene SH3BP2 cause variable clinical involvement (variable expressivity), involvement can be moderate,
severe or may result merely in asymptomatic carriers. Since the possibility of transmission reaches 50% of chances,
we believe that it is important to develop genetic counseling for both patients and carriers, in order to prevent or
minimize new affected offspring.
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Cherubism, listed by OMIM (Online Mendelian Inherit-
ance in Man) as OMIM 118400, is a rare genetic disease
of dominant autosomal inheritance with variable pene-
trance and expressivity, characterized by an abnormal
growth of the bones of the face, mainly the jaw [1].
Prevalence is unknown, but is probably less than 1 in
10,000 [2]. In general, it appears around age 4 with pain-
less bilateral swelling of the jaws (which create a
cherubim-like look) and stops progression in the late
teens, with residual manifestations persisting in adult life
[3]. The term cherubism was suggested to describe the
appearance of the patients due to their resemblance to a
Renaissance cherub [4].
Cherubism is classified within the group of benign osteo-
fibrous lesions, differentiating from osteo-cementum lesions
and fibrous dysplasia because of its unique clinical and
radiological features [1]. Besides facial deformities, there* Correspondence: perezsayans@gmail.com
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distribution, and reproduction in any mediummay be complications, including vision loss due to optic
neuropathy, obstruction of upper airways, sleep apnea, lan-
guage disorders and difficulty chewing due to alterations in
the appearance and development of teeth [5]. Teething is
also abnormal and dental agenesis, lack of eruption, dis-
placement, root resorption and malocclusions are common
problems. X-ray imaging contributes to the diagnosis show-
ing multiocular radiolucencies that are well defined and,
with age, thick sclerotic lines, usually symmetrical [6]. The
definitive diagnosis is made histologically, with the appear-
ance of randomly distributed multinucleated giant cells and
vascular spaces within the stroma of the fibrous connective
tissue. These multinucleated giant cells are positive for
osteoclast-specific markers [7].
It has been observed that the disease is due to a muta-
tion in gene SH3BP2, which is located at chromosome
4pl6.3, which encodes a protein formed by 561 amino
acids [8]. In patients with cherubism, mutations have
only been described in exon 9 of gene SH3PB2. To date,
mutations in the other exons of this gen have not been
described. It has also been related to a range of other
diseases such as Noonan and Noonan-like syndromes
(caused by mutations in gene PTPN11), and Ramon’sentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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type I neurofibromatosis [9].
Here we present two cases of familial cherubism, uncle
and nephew (hereinafter, Patient 1 and 2, respectively)
(Figure 1), with variable clinical involvement (“Expressiv-
ity”), together with the radiological description and the
molecular confirmation of the case through the detec-
tion of a mutation in gene SH3BP2 (SH3-domain bind-
ing protein 2). After PCR, the entire coding region
including intron-exon boundaries of the exon 9 of the
SH3BP2 gene was analyzed by bidirectional sequencing
(Big Dye Terminator v3.1, LifeTechnologies) using an
ABI3730XL Analyzer (Applied biosystems, Foster City,
CA, USA).
Consent
Written informed consent was obtained from the patients
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal. The present
study was approved by the CHUS research ethics
committee.
Results
Our patients are a man (Patient 1), the first familial
cherubism case, which was diagnosed in the year 1985 at
the age of 9 years; and his nephew (Patient 2), who wasFigure 1 Family involvement scheme of cherubism disease.
Arrow: polypoid formation in the right maxillary sinus. Asterisks:
multiple epidermal cysts.diagnosed with cherubism in 2013 at the age of 7 years.
Patient 1, who is currently 37 years old, visited the
Maxillofacial Surgery Unit due to severe tooth malposi-
tioning. After radiological examination using panoramic
X-rays, we confirmed the presence of multiple epider-
mal cysts with numerous malpositioned teeth, and a
polypoid formation in the right maxillary sinus (Figure 2).
We performed an extraction of all lower teeth except for
piece 36 and the deep inclusions of premolars (34 and 35)
and we performed curettage of the bone lesions. We col-
lected biopsies from soft and hard tissue and teeth. The
anatomical and pathological report confirmed fibroblastic
lesions with a prominent vascular pattern, dotted with
abundant multinucleated giant cells and newly formed
bone in the peripheral areas, which supports cherubism
after discarding the brown tumor of hyperparathyroidism.
Patient 1 also had orbital involvement, and microstrabis-
mus and neuropathic vision loss. The orbital involvement
required inferior orbitotomy with resection and orbital
floor removal and placement of a Medpor Orbital Recon-
struction Implants prosthesis (Stryker, Kalamazoo, USA)
to reinforce the orbital floor. According to the Raposo-
Amaral classification [10], it would be grade VI, due to the
rare involvement of the jaw, maxillary sinus and orbit.
Patient 1 has two siblings, a man and a woman, neither
of them is affected by the disease. The sister (Figure 3) has
two children. Her firstborn (Patient 2) is 8 years old. He
visited the Maxillofacial Surgery Unit due to the delay of
the eruption of permanent incisors without suspecting
any relation to his uncle’s pathology. Upon radiological
examination, we observed the lack of eruption of perman-
ent upper teeth, germination of lower central incisors,
follicular cyst inclusion in piece 43, horizontal ectopic
inclusion of tooth 32, supernumerary jaw, and odonto-
genic cysts in posterior mandibular regions and right
mandibular area (Figure 4). We immediately suspected
familial cherubism. Furthermore, Patient 2 referred
nonspecific headaches that disappeared with nonsteroi-
dal anti-inflammatory drugs, so we evaluated a possible
ocular involvement, which has not been confirmed yet.
According to the Raposo-Amaral classification, it wouldFigure 2 Panoramic radiography of the uncle affected.
Figure 3 Panoramic radiography of the sister, non-affected.
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trition, O-LAC (Mead Johnson).
In these two clinical cases, we decided to conduct a
confirmatory molecular study of the uncle (Patient 1),
mother, and her firstborn son (Patient 2) and develop a
predictive study of Patient 2′s younger brother, who is
now 5 years old and clinically asymptomatic. EDTA
blood samples were collected for sequencing analysis in
all patients. The analysis consisted of the capillary se-
quencing of the amplified exon 9 of gene SH3BP2.
For Patient 1, with extreme phenotype, we observed a
genotype: SH3BP2 R415Q/normal (in HGVS nomencla-
ture: c. [1244G > A], [=]), showing that the mutation of
R415Q causes a change in the Arg amino acid by Gln at
position 415 of the protein and is described as patho-
logic with reduced penetration and variable expression.
This result confirms the diagnosis of cherubism in which
the chances of transmitting the mutation amount to
50%. Meanwhile, in the mother, with healthy phenotype,
we also observed a SH3BP2 R415Q/normal genotype
with the same likelihood of transmission. The eldest son,
the sibling affected by an extreme phenotype, showed
the same genotype SH3BP2 R415Q/normal. However,
the youngest son, who is phenotypically asymptomatic,
presented a SH3BP2 normal/normal genotype and doesFigure 4 Panoramic radiography of the nephew, affected.
Arrow: follicular cyst in piece 43. Asterisks: odontogenic cysts in
posterior mandibular regions and right mandibular area.not carry the mutation. Therefore he is not at risk of de-
veloping the disease or transmitting it.
Discussion
Cherubism is an autosomal dominant disease, with
variable expressivity (different from the classical con-
cept of “penetrance”) [11]. By sex, expressivity amounts
to nearly 100% in men, and shows reduced expression
in women ranging from 50 to 75%, although sporadic
cases of cherubism have been reported [12,13]. This
can be seen in the family that we describe, both men
have clearly established cherubism, while the woman is
completely asymptomatic.
Clinically there is a painless enlargement of the lower
half of the face, which starts approximately at age 3 or 4
and continues through to adolescence. In most cases this
growth stops at the end of adolescence, thus the typical
appearance of cherubism disappears when these lesions
regress around age 20 and residual lesions are not
recognizable. Residual deformity of the jaw is uncom-
mon. The rest of the skeleton is not affected, and
markers of bone remodeling are within normal range
[3,7]. Raposo-Amaral [10], presents a clinical classifica-
tion of VI degrees of expression of the disease. We be-
lieve that this classification is useful when comparing
the clinical situation of patients. However, we wish to
present a modification of this classification by introdu-
cing degree 0, which would include individuals who in-
herit the mutation of SH3BP2 but do not present any
type of expression of the disease (Table 1). Therefore, in
regards of the members of the family presented here,
and according to our classification, the mother would be
grade 0, the uncle would be grade VI, whereas the
nephew would have grade III.
The differential diagnosis must be made with fibrous
dysplasia, odontogenic cyst, juvenile ossifying fibroma,
giant cell granuloma, fibrous osteoma, osteosarcomae
hyperparathyroidism. The histopathology is characterizedTable 1 Proposed clinical classification for cherubism,
modified from Raposo-Amaral classification [10]
Grade Definition
0 Existence of the mutation without expression of the disease.
I Lesion of the mandible without signs of root resorption
II Lesions involving the mandible and maxilla without signs of
root resorption
III Aggressive lesion of the mandible with signs of root resorption
IV Lesions involving the mandible and maxilla with signs of Root
resorption
V The rare, massively growing, aggressive, and extensively
deforming juvenile lesions involving the maxilla and mandible
VI The rare, massively growing, aggressive, and extensively
deforming juvenile lesions involving the maxilla, mandible,
and orbits
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throughout the fibro-osseous connective tissue, with the
presence of spindle cells and osteoid trabeculae [14].
We must clarify a persistent error in many of the pa-
pers dealing with cherubism, which affirm that the le-
sions that appear in the jaws are cysts. This is absolutely
false, since a cyst is a pathological cavity (often filled
with liquid) that is surrounded by epithelium [15]. In
cherubism, the lesions that insufflate the jaws are essen-
tially tissue masses similar to giant cell granulomas. We
believe that this error derives from the first description
of the disease, which was coined by Jones: “Familial mul-
tilocular cystic disease of the jaws” [4].
Ueki et al. [8] identified mutations in gene SH3BP2,
which caused cherubism and established the genetic
basis for classifying the disease as a separate entity of fi-
brous dysplasia of the jaws. Gene SH3BP2 is located at
4p16.3 and transcribes a protein of 561 amino acids that
binds to the SH3 domains of certain transducer proteins,
having proven its expression in multi-nucleated cells and
the stromal cells of fibrous tissue of cystic lesions of af-
fected patients [16]. Although this mutation persists
throughout the life of the patient, the expression of the re-
lated genes changes with age (unknown mechanism) and
the existing lesions tend to auto-resolve in adulthood [2,6].
There have been reports of cherubism cases associated
with Noonan syndrome without showing mutations at
gene SH3BP2, which is considered as an expression of
the disease rather than two related entities [9]. The asso-
ciation between Ramon’s syndrome [17] and the Jaffe-
Campanacci [18] and the fragile X syndrome [19] has
also been described. The most common genetic abnor-
mality is the R415Q mutation that causes a change in
amino acid Arg by Gln at position 415 of the protein [8].
Other mutations have been described for the same gene,
with varying degrees of clinical involvement. Li et al.
[20] describe the change of the base of A1517G that
causes a substitution of the D419G amino acid. Carvalho
et al. [21], describe a mutation corresponding to the de-
letion of cytosine (408 of C), located in the PH domain
in SH3BP2. Lietman et al. [22] describe a missense muta-
tion (aspartic acid to asparagine, p.D419N (g.1371G > A,
c.1255G >A) in exon 9 of SH3BP2. Other mutations
described are: p.D420E (c.1259G > A) [23], and p.P418R
(c.1253C >G) [8].
Other hypotheses have been described in the patho-
genesis of cherubism. Thus, Hyckel et al. consider that
cherubism is a disorder induced by altered signals in the
transduction of the parathyroid hormone due to the in-
fluence of protein SH3BP2 in the regulation of the union
of the receptor of the parathyroid-hormone and Parathy-
roid hormone-related protein (PTHrP) [24].
The main complications described in the disease are
optic neuropathy caused by orbital involvement, sleep,speech and chewing disorders and airway obstruction
[5,7]. In the cases presented, one of the patients had or-
bital and ophthalmic involvement with no signs of optic
neuritis, while the other patient has not presented any
other problem aside from the dentoskeletal deformity of
the jaws and the resulting difficulty chewing.
To treat cherubism, in Patient 1′s case, we have
resorted to surgical decompression of the orbit and a re-
constructive surgery of the jaws [3], but sometimes one
can opt for watchfully waiting for the involution of the
lesions that is expected by the end of adolescence. In the
family that we studied, we were able to confirm the pres-
ence of the same mutation in the heterozygous genotype,
resulting in a dominant inheritance and not a denovo
mutation.
Conclusions
In this article we have shown that, in familial cherubism
cases, the mutation is inherited through an autosomal
dominant transmission. Mutations affecting gene SH3BP2
cause variable clinical involvement (variable expressivity),
involvement can be moderate, severe or may result merely
in asymptomatic carriers. Since the possibility of transmis-
sion reaches 50% of chances, we believe that it is import-
ant to develop genetic counseling for both patients and
carriers, in order to prevent or minimize new affected
offspring.
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